We are live on ! Find out more
BLTE

Belite Bio

34 hedge funds and large institutions have $169M invested in Belite Bio in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,656% more capital invested

Capital invested by funds: $4.51M → $169M (+$165M)

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

89% more funds holding

Funds holding: 1834 (+16)

6.94% more ownership

Funds ownership: 0.25%7.19% (+6.9%)

Holders
34
Holders Change
+16
Holders Change %
+88.89%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
12
Reduced
5
Closed
Calls
Puts
Net Calls
Net Calls Change

BLTE Hedge Fund Activity: Q3 2025 in Review

34 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2025, worth a combined $169M — up 3,656% from $4.51M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BLTE positions and 0 closed out — a net gain of 16 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $57.4M. The largest seller was State Street, cutting an estimated $455K.

  • 34 institutional investors held Belite Bio (BLTE) as of Q3 2025, up from 18 in Q2 2025.
  • Funds reported $169M of Belite Bio stock for Q3 2025, up 3,656% quarter-over-quarter.
  • 16 funds opened new Belite Bio positions in Q3 2025 and 0 closed out, a net change of +16 holders.
  • The largest Belite Bio buyer in Q3 2025 was RA Capital Management, an estimated $57.4M added.
  • The largest Belite Bio seller in Q3 2025 was State Street, an estimated $455K sold.

Based on aggregated 13F filings for Q3 2025.